Susan L. Levinson
Amministratore Delegato presso BioAegis Therapeutics, Inc.
Profilo
Susan L.
Levinson is the founder of BioAegis Therapeutics, Inc. She is currently a Director at Azure Biotech, Inc. and a Trustee at BioNJ, Inc.
Posizioni attive di Susan L. Levinson
Società | Posizione | Inizio |
---|---|---|
BioAegis Therapeutics, Inc.
BioAegis Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology BioAegis Therapeutics, Inc. manufactures medicinal chemicals. It develops a portfolio of biomarker-directed treatments for a range of indications. The company was founded by Susan L. Levinson and is headquartered in North Brunswick, NJ. | Amministratore Delegato | - |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direttore/Membro del Consiglio | - |
Azure Biotech, Inc.
Azure Biotech, Inc. BiotechnologyHealth Technology Azure Biotech, Inc. is a private biotechnology company that is developing an alternative product to address the many drawbacks of current therapies for vulvovaginal atrophy (VVA). The company is based in New York, NY. The company has the exclusive worldwide rights to all topical formulations of lasofoxifene, a selective estrogen receptor modulator (SERM). Azure plans to rapidly build upon the extensive safety and efficacy data already available from clinical trials previously completed with an oral formulation in more than 15,000 women. The company was founded by David Thompson. | Direttore/Membro del Consiglio | 01/08/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
BioAegis Therapeutics, Inc.
BioAegis Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology BioAegis Therapeutics, Inc. manufactures medicinal chemicals. It develops a portfolio of biomarker-directed treatments for a range of indications. The company was founded by Susan L. Levinson and is headquartered in North Brunswick, NJ. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Azure Biotech, Inc.
Azure Biotech, Inc. BiotechnologyHealth Technology Azure Biotech, Inc. is a private biotechnology company that is developing an alternative product to address the many drawbacks of current therapies for vulvovaginal atrophy (VVA). The company is based in New York, NY. The company has the exclusive worldwide rights to all topical formulations of lasofoxifene, a selective estrogen receptor modulator (SERM). Azure plans to rapidly build upon the extensive safety and efficacy data already available from clinical trials previously completed with an oral formulation in more than 15,000 women. The company was founded by David Thompson. | Health Technology |
- Borsa valori
- Insiders
- Susan L. Levinson